IRadimed logo

IRadimed

IRMD | NASDAQ
Chart Builder DCF Calculator
$84.84
-$0.51 (-0.60%)
At close: Nov 16, 2026, 4:00 PM ET
$85.85
+$1.01 (+1.19%)
After-hours: Nov 16, 2026, 7:32 PM ET
-0.60%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
70.9
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #48/1021 (Top 5%)

Key Statistics

Market Data

Market Cap $1.08B
1D Range
83.97 85.20
52W Range
76.68 105.15

Valuation (TTM)

PE 45.37
PB 10.19
EV/EBITDA 32.06

Valuation (NTM)

Forward PE 40.64
Forward PEG 3.64
Price Target $120.00
Loading financial charts...

Profile

IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The com...

Sector Healthcare
Employees 166
IPO Date Jul 16, 2014
Fiscal Year January - December

Latest News

What iRadimed (IRMD) Said on Its Q3 Earnings Call

18 days ago · marketbeat.com

What iRadimed (IRMD) Said on Its Q3 Earnings Call
IRADIMED CORPORATION (IRMD) Q3 2026 Earnings Call Transcript

18 days ago · seekingalpha.com

IRADIMED CORPORATION (IRMD) Q3 2026 Earnings Call Transcript
IRADIMED CORPORATION Reports Third Quarter 2026 Financial Results

18 days ago · globenewswire.com

IRADIMED CORPORATION Reports Third Quarter 2026 Financial Results
IRADIMED CORPORATION to Hold Third Quarter 2026 Financial Results Conference Call on October 30, 2026

25 days ago · globenewswire.com

IRADIMED CORPORATION to Hold Third Quarter 2026 Financial Results Conference Call on October 30, 2026
IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference

2 months ago · globenewswire.com

IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference
iRadimed Corp (IRMD) Stock Down 3.8% but Still Overvalued -- GF Score: 92/100

2 months ago · gurufocus.com

iRadimed Corp (IRMD) Stock Down 3.8% but Still Overvalued -- GF Score: 92/100
iRadimed Q2 Earnings Call Highlights

4 months ago · marketbeat.com

iRadimed Q2 Earnings Call Highlights
IRADIMED CORPORATION (IRMD) Q2 2026 Earnings Call Transcript

4 months ago · seekingalpha.com

IRADIMED CORPORATION (IRMD) Q2 2026 Earnings Call Transcript
IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results

4 months ago · globenewswire.com

IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026

4 months ago · globenewswire.com

IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026

Earnings

Latest Earnings
Oct 30, 2026
EPS
$0.55
Beat 0.00%
REV
$24.2M
Beat +3.12%
Next Earnings
Feb 9, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.